Keywords: ucb, verus, commercialize, twinject, europe, belgian, drugmaker

UCB and Verus to commercialize Twinject in Europe

Article | 28 August 2006

Belgian drugmaker UCB says that it has entered into an agreement with USA-based Verus Pharmaceuticals, covering the European commercialization of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

UCB

Go to company listing

Related Drugs

Adrenalin

Epinephrine

Go to drug listing